Abstract
Purpose: The anticonvulsant activity of neuropeptide Y (NPY) in the hippocampus is generally attributed to an inhibition of glutamate release
from presynaptic terminals. This hypothesis, which was advanced on the basis of in vitro observations, has not been verified in vivo. In the
present study, we used intracerebral microdialysis to determine the effect of NPY on hippocampal extracellular glutamate concentration in
vivo, and to identify the NPY receptor subtype that mediates this effect.
Method: Freely moving male Wistar rats underwent a 2 hour intrahippocampal administration of a known anticonvulsant concentration of
NPY (20_M), an equivalent concentration of the selective Y1 receptor agonist D-His26-NPY (20_M) or co-administration of NPY (20_M) and
the Y1 receptor antagonist BVD10 (2_M) via a stereotactically implanted microdialysis probe. Changes in glutamate dialysate concentration
were monitored.
Result: Intrahippocampal microperfusion of NPY or D-His26-NPY increased glutamate dialysate concentration. Hippocampal Y1
receptor blockade (BVD10) reversed the NPY-induced increase in glutamate dialysate concentration.
Conclusion: Local administration of an anticonvulsant concentration of NPY increases hippocampal glutamate overflow in vivo, through
activation of hippocampal Y1 receptors. These findings are at odds with the current hypothesis regarding NPY's mechanism of action in
epilepsy. Further experiments are needed to determine the origin and functional relevance of NPY-induced increases in hippocampal
extracellular glutamate.
from presynaptic terminals. This hypothesis, which was advanced on the basis of in vitro observations, has not been verified in vivo. In the
present study, we used intracerebral microdialysis to determine the effect of NPY on hippocampal extracellular glutamate concentration in
vivo, and to identify the NPY receptor subtype that mediates this effect.
Method: Freely moving male Wistar rats underwent a 2 hour intrahippocampal administration of a known anticonvulsant concentration of
NPY (20_M), an equivalent concentration of the selective Y1 receptor agonist D-His26-NPY (20_M) or co-administration of NPY (20_M) and
the Y1 receptor antagonist BVD10 (2_M) via a stereotactically implanted microdialysis probe. Changes in glutamate dialysate concentration
were monitored.
Result: Intrahippocampal microperfusion of NPY or D-His26-NPY increased glutamate dialysate concentration. Hippocampal Y1
receptor blockade (BVD10) reversed the NPY-induced increase in glutamate dialysate concentration.
Conclusion: Local administration of an anticonvulsant concentration of NPY increases hippocampal glutamate overflow in vivo, through
activation of hippocampal Y1 receptors. These findings are at odds with the current hypothesis regarding NPY's mechanism of action in
epilepsy. Further experiments are needed to determine the origin and functional relevance of NPY-induced increases in hippocampal
extracellular glutamate.
| Original language | English |
|---|---|
| Journal | Epilepsia |
| Publication status | Published - 2008 |
| Event | Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet - Stockholm, Sweden Duration: 21 Sept 2009 → 25 Sept 2009 |
Keywords
- neuropeptide Y
- hippocampus
- epilepsy
- glutamate
Fingerprint
Dive into the research topics of 'Neuropeptide Y increases extracellular glutamate concentration in the hippocampus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver